AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21716277
Drug: LBM415 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBM415 at 1,000 mg b.i.d.
Trial: 21716277
Drug: LBM415 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBM415 at 1,000 mg t.i.d.
Trial: 21716277
Drug: LBM415 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBM415 at low doses (not specified)
Trial: 21716277
Drug: LBM415 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBM415 at 1,000 mg single dose
Trial: 15296889
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) 1.5 g as a bolus, followed by a constant infusion of 200 mg/h until 1.5 g
Trial: 28303632
Drug: UFH monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH monotherapy
Trial: 16684823
Drug: Metformin (425
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (425 mg/d) for 2 years
Trial: 15277255
Drug: Doxorubicin 50
RxNorm normalized name: DOXOrubicin 50 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 50 mg/m2 i.v. followed by paclitaxel 150 mg/m2 i.v. over 24 h plus filgrastim 5 microg/kg on days 3-12 (arm 2)
Trial: 15277255
Drug: Doxorubicin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 60 mg/m2 i.v. followed by cisplatin 50 mg/m2 i.v. (arm 1)
Trial: 11351769
Drug: Formoterol via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol via Aerolizer inhaler (12 micrograms twice daily)
Trial: 11351769
Drug: Formoterol via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol via Turbuhaler inhaler (12 micrograms twice daily)
Trial: 9236262
Drug: Ipriflavone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipriflavone (200 mg t.i.d.)
Trial: 3092363
Drug: Triaging patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triaging patients into various combinations of health education treatments
Trial: 29795295
Drug: 0.1% GRFT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% GRFT gel (HEC formulation)
Trial: 29795295
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel (HEC formulation)
Trial: 27180881
Drug: Arnebia euchroma
RxNorm normalized name: ARNEBIA EUCHROMA ROOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arnebia euchroma ointment (AEO)
Trial: 25730540
Drug: Silver sulfadiazine
RxNorm normalized name: Silver Sulfadiazine
DrugBank: Silver sulfadiazine (DB05245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver sulfadiazine cream (SSD)
Trial: 21455255
Drug: DOCp53 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOCp53 group (trans-tracheal Adp53 injection at 1 × 10(12) vp on day 1 and day 8, plus docetaxel at 75 mg/m² on day 2)
Trial: 21455255
Drug: DOC group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOC group (docetaxel at 75 mg/m² on day 1)
Trial: 24944393
Drug: Manidipine 10
RxNorm normalized name: manidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine 10 mg plus delapril 30 mg once daily for 12 weeks (Group 1)
Trial: 24944393
Drug: Manidipine 10
RxNorm normalized name: manidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine 10 mg plus delapril 30 mg once daily for 12 weeks (Group 2)
Trial: 8855179
Drug: Ciprofloxacin and
RxNorm normalized name: ciprofloxacin and ornidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin and a combination of amoxicillin and clavulanic acid for 3 days after hemorrhage (group 3)
Trial: 1900488
Drug: Estrogen/progestin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen/progestin administration
Trial: 31987245
Drug: Isometric treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isometric treatment
Trial: 19307437
Drug: Compression, sclerotherapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression, sclerotherapy, surgery, and endoluminal treatments
Trial: 15493034
Drug: Antimycotic self-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimycotic self-treatment with antifungal oral gel and antiseptic solution for dentures
Trial: 8141577
Drug: Foscarnet induction
RxNorm normalized name: foscarnet Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foscarnet induction treatment
Trial: 3125973
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg thymostimulin (TS) i.m. daily for 35 days (G1)
Trial: 3125973
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg thymostimulin (TS) i.m. every other day for 35 days (G2)
Trial: 3125973
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (G3)
Trial: 3125973
Drug: Thymostimulin maintenance
RxNorm normalized name: thymostimulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymostimulin maintenance therapy
Trial: 3125973
Drug: Thymostimulin treatment
RxNorm normalized name: thymostimulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymostimulin treatment
Trial: 30597771
Drug: PF-04447943 25
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: PF-04447943 25 mg
Trial: 26548737
Drug: Typical chiropractic
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical chiropractic care only (manual therapy and exercises)
Trial: 26548737
Drug: Typical chiropractic
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical chiropractic care with daily home use of the self-acupressure pillow (SAP)
Trial: 18452778
Drug: Bivalirudin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin monotherapy (switched from UFH/ENOX)
Trial: 18452778
Drug: Bivalirudin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin monotherapy (naive to antithrombin therapy)
Trial: 18452778
Drug: UFH/ENOX plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH/ENOX plus GP IIb/IIIa inhibitor (consistent therapy)
Trial: 18452778
Drug: UFH/ENOX plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH/ENOX plus GP IIb/IIIa inhibitor (naive patients)
Trial: 11074742
Drug: Nicotine inhaler
RxNorm normalized name: nicotine Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine inhaler plus nicotine patch (delivering 15 mg of nicotine per 16 hours) for 6 weeks, then inhaler plus placebo patch for 6 weeks, then inhaler alone for 14 weeks
Trial: 11074742
Drug: Nicotine inhaler
RxNorm normalized name: nicotine Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine inhaler plus placebo patch for 12 weeks, then inhaler for 14 weeks
Trial: 2866966
Drug: Propranolol and
RxNorm normalized name: propranolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol and Atenolol (Control Beta-blockers)
Trial: 30657353
Drug: Prediction-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prediction-based treatment
Trial: 28482405
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon α‐2b (Y shape, 40 kD) injection (180 µg/week) combined with ribavirin
Trial: 28482405
Drug: Standard-dose Peg‐IFN‐α‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose Peg‐IFN‐α‐2a combined with ribavirin
Trial: 25064421
Drug: STAGE‐12 therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STAGE‐12 therapy (high exposure, n=158)
Trial: 16982815
Drug: Flow rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flow rate of 8 mL/sec
Trial: 16982815
Drug: Flow rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flow rate of 4 mL/sec
Trial: 16982815
Drug: Flow rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flow rate of 8 mL/sec with individualized scan delay
Trial: 16982815
Drug: Flow rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flow rate of 4 mL/sec with fixed scan delay
Trial: 11103232
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CDDP and 5-FU with chemo- and radiotherapy
Trial: 8882105
Drug: Topical 4%
RxNorm normalized name: menthol topical 4% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 4% lidocaine with antibiotic drops
Trial: 8882105
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with antibiotic drops
Trial: 28893875
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg zoledronate
Trial: 28893875
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg zoledronate
Trial: 19050050
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg zoledronate
Trial: 22072741
Drug: zoledronate (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zoledronate (all doses)
Trial: 29151034
Drug: ezetimibe/simvastatin 10/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin 10/40 mg
Trial: 20487050
Drug: rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 5 or 10 mg
Trial: 18579811
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of oral rivaroxaban once daily
Trial: 18579811
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of enoxaparin subcutaneously once daily
Trial: 16049380
Drug: EASI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EASI plus high dose oxytocin
Trial: 12444817
Drug: Fluoxetine, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine, 20 to 80 mg/day (N = 30)
Trial: 10638387
Drug: Paracetamol 10
RxNorm normalized name: Paracetamol 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 10 mg/kg thrice daily
Trial: 10638387
Drug: Ibuprofen 10
RxNorm normalized name: ibuprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 10 mg/kg thrice daily
Trial: 10638387
Drug: Nimesulide 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 2.5 mg/kg twice daily for 5 days
Trial: 7569731
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (n-3 PUFAs) supplementation, 4 g per day for 6 months
Trial: 1940932
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg three times daily for 10 days starting on the first postoperative day
Trial: 6266028
Drug: Subcutaneous calcium
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous calcium heparin, 5000 units (Ul) 2 hours and 30 minutes before surgery then every 12 hours for 15 days (Protocol A)
Trial: 6266028
Drug: Subcutaneous calcium
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous calcium heparin, same dose and duration starting 24 to 72 hours after surgery (Protocol B)
Trial: 6266028
Drug: No anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anticoagulant treatment (Protocol O)
Trial: 30863894
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose soy drink (35 mg/day isoflavones) for 12 weeks
Trial: 30863894
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose soy drink (10 mg/day isoflavones) for 12 weeks
Trial: 30863894
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose soy drink (60 mg/day isoflavones) for 12 weeks
Trial: 31250285
Drug: SHAM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHAM treatment
Trial: 21251813
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (n=79)
Trial: 21251813
Drug: 3-weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly docetaxel (n=77)
Trial: 19703948
Drug: Vulnamin gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vulnamin gel with elastocompression
Trial: 19703948
Drug: Inert gel
RxNorm normalized name: inert ingredients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inert gel vehicle with elastocompression
Trial: 8622022
Drug: CEF chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEF chemotherapy (first-line treatment)
Trial: 18562328
Drug: Anthracycline-based adjuvant
RxNorm normalized name: Rna-based adjuvant cv8102
DrugBank: CV-8102 (DB19184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-based adjuvant chemotherapy
Trial: 8622022
Drug: Not receiving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not receiving adjuvant chemotherapy
Trial: 7326852
Drug: 40 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 micrograms of triiodothyronine (T3) daily
Trial: 24046400
Drug: Diluent containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diluent containing 0.30 µg of 25(OH)D3
Trial: 24046400
Drug: Diluent containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diluent containing 0.60 µg of 25(OH)D3
Trial: 24046400
Drug: Diluent containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diluent containing 1.20 µg of 25(OH)D3
Trial: 21492164
Drug: Oltipraz 60
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 60 mg bid for 24 weeks
Trial: 21492164
Drug: Oltipraz 90
RxNorm normalized name: Oltipraz
DrugBank: Oltipraz (DB12539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oltipraz 90 mg qd for 24 weeks
Trial: 16472330
Drug: rizatriptan 10-mg
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rizatriptan 10-mg wafer
Trial: 15658651
Drug: Liuwei Dihuang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liuwei Dihuang Pill (LDP) plus conventional therapy (Gliquidone or insulin) for 3 months
Trial: 15658651
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (Gliquidone or insulin)
Trial: 10027034
Drug: 10% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% lidocaine aerosol (2.5-4.7 mg kg-1)
Trial: 7628183
Drug: Zifrosilone 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zifrosilone 10 mg
Trial: 7628183
Drug: Zifrosilone 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zifrosilone 300 mg
Trial: 7628183
Drug: Zifrosilone doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zifrosilone doses > or = 200 mg
Trial: 7018557
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg oestriol gel
Trial: 7018557
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg PGF2 alpha gel
Trial: 2673340
Drug: gel alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gel alone (control)
Trial: 30010353
Drug: Tension Tamer
RxNorm normalized name: Ascorbic Acid/Chamomile/Cyanocobalamin/Kava/Magnesium/Pyridoxine/St John's Wort 150 MG-100 MG-0.006 MG-100 MG-25 MG-3 MG-50 MG Oral Capsule [TENSION TAMER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tension Tamer (TT) guided BAM sessions for 5-, 10-, or 15-min intervals twice daily over 6 months
Trial: 27657471
Drug: Nicorandil (5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (5mg thrice daily for 12 weeks)
Trial: 27657471
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus nicorandil
Trial: 24767094
Drug: Higher volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher volume of whole blood (30 ml/kg; Tx30)
Trial: 24767094
Drug: Standard volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard volume of whole blood (20 ml/kg; Tx20)
Trial: 22218843
Drug: Montelukast (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (4 mg oral, 12-week treatment)
Trial: 22218843
Drug: Placebo (look-alike,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (look-alike, 12-week treatment)
Trial: 7594336
Drug: lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole (30 mg/day)
Trial: 28541646
Drug: Cognitive Rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST)
Trial: 30104294
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 300 units/mL (Gla‐300)
Trial: 28418213
Drug: Lidocaine (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (0.25, 0.50, 1.0 or 10 mg/mL)
Trial: 21595743
Drug: Methylprednisolone 20
RxNorm normalized name: methylprednisolone 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 20 mg/day for 7 days
Trial: 21595743
Drug: Anti-TNF (adalimumab,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF (adalimumab, Humira®) 40 mg s.c. single dose
Trial: 11679026
Drug: Passiflora extract
RxNorm normalized name: Passiflora incarnata extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passiflora extract 45 drops/day plus placebo tablet
Trial: 11679026
Drug: Oxazepam 30
RxNorm normalized name: oxazepam 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 30 mg/day plus placebo drops
Trial: 7889022
Drug: Injectable haloperidol
RxNorm normalized name: haloperidol Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable haloperidol decanoate 141 mg/ml (test product)
Trial: 30544411
Drug: Oxycodone 4
RxNorm normalized name: OXYCODONE 4.88MG/ASA 325MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 4 mg (group O)
Trial: 30544411
Drug: Fentanyl 50
RxNorm normalized name: fentanyl 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 50 μg (group F)
Trial: 27166238
Drug: JZP-110 150
RxNorm normalized name: JZP-386 free base
DrugBank: JZP-386 free base (DB17068)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JZP-110 150 mg/day weeks 1-4 and 300 mg/day weeks 5-12
Trial: 19057854
Drug: rhu EPO,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhu EPO, 500u per kg, per week, 2 times weekly, subcutaneous
Trial: 16176313
Drug: Sevoflurane anesthesia
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane anesthesia with mivacurium (0.2 mg.kg(‐1))
Trial: 16176313
Drug: Propofol anesthesia
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol anesthesia with mivacurium (0.2 mg.kg(‐1))
Trial: 9063758
Drug: Policosanol 5
RxNorm normalized name: policosanol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 5 mg
Trial: 9063758
Drug: Policosanol 10
RxNorm normalized name: policosanol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 10 mg
Trial: 9063758
Drug: Policosanol 20
RxNorm normalized name: POLICOSANOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 20 mg
Trial: 9063758
Drug: Policosanol 25
RxNorm normalized name: Cayenne/Garlic/Guggulsterone/Niacin/Phytosterols/Policosanol 25 MG-25 MG-50 MG-25 MG-100 MG-5 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 25 mg
Trial: 9063758
Drug: Policosanol 50
RxNorm normalized name: POLICOSANOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 50 mg
Trial: 10959738
Drug: Oral Polio
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Polio Vaccine (OPV)
Trial: 1845806
Drug: Enhanced-Potency Inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced-Potency Inactivated Polio Vaccine (E-IPV)
Trial: 6338689
Drug: Digoxin 0.375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin 0.375 mg
Trial: 22947589
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 50,000 IU weekly for 8 weeks
Trial: 15124669
Drug: High-dose AraC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose AraC during induction therapy